The Venture Collective
VC Fund
New York, United States
The Venture Collective is a VC fund in New York focused on Health Care and Biotechnology. TVC is a transformational, early-stage venture firm backed by world class entrepreneurs and business leaders. Led by a seasoned team of venture investors, ex-founders, and investment management executives, we invest our capital, time, and network into highly defensible, fast-growing companies with the potential to solve the world’s largest problems. Our strategy is grounded on writing high conviction checks at Pre-Seed and Seed with healthy follow-on reserves through Series A; demonstrating deep value to enable increased ownership over time. Our experienced team is headquartered in New York City and London, but we are excited to meet founders from around the world with a strong preference for diverse founding teams. At its core, we believe that diversity is not only good for business, but great for financial returns.
- Total investments:
- 58
- Last investment:
- Lead investor:
- 19%
Last updated:
For AI agents: llms.txt
Industries The Venture Collective invests in
Stages The Venture Collective invests in
Countries The Venture Collective invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Seed
- $2.7M–$20M
- Pre-Seed
- $410k–$1.9M
- Series A
- $10M–$52M
Investment Focus
Industry
- Health Care 13 (22%)
- Biotechnology 11 (19%)
- Artificial Intelligence 6 (10%)
- Medical 5 (9%)
- FinTech 4 (7%)
Stage
- Seed 23 (40%)
- Series A 13 (22%)
- Pre-Seed 5 (9%)
- Series B 5 (9%)
- Venture - Series Unknown 3 (5%)
Country
- United States 25 (43%)
- United Kingdom 10 (17%)
- Germany 2 (3%)
- India 1 (2%)
- Mexico 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Adam Devine
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
Kristin Thayer
Venture Partner
|
Venture Partner | Total investments: 1 | Find email | |
Cat Hernandez
Partner
|
Partner | Total investments: 3 | Find email | |
Gina Kirch
Founding Partner
|
Founding Partner | Total investments: 1 | Find email | |
Greg Arrese
Venture Partner
|
Venture Partner | Total investments: 16 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve. | $100M / Series A / Oct 08, 2026 | ||
| Eterna Regeneratives develops regenerative biomaterials for mineralisation and tissue regeneration. | $4M / Seed / Sep 16, 2026 | ||
| Wizard Wellness is a drug-free allergy care brand reimagining sinus health through nasal microbiome science. It develops wellness-focused products like probiotic nasal sprays, inhalers, oral strips, and sinus rinse kits designed to support nasal balance and reduce irritation from allergens. Founded in 2025, the company blends skincare-styleroutines with biotech-inspired ingredients to deliver daily, non-medicated allergy relief and long-term nasal wellness. | $8M / Seed / Sep 03, 2026 | ||
| Cocoon provides environmental consulting services to businesses and develops solutions to analyze and eradicate industrial waste. | $15M / Series A / Mar 18, 2026 | ||
| Unnatural Products is a startup pairing AI with chemistry to create treatments for drug targets. Its AI-enhanced technology platform creates entirely new drugs by engineering passively permeable, macrocyclic peptides that access traditionally undruggable targets.Unnatural Products was founded in 2017 and is headquartered in Santa Cruz,California. | $45M / Series B / Mar 16, 2026 | ||
| Orbem is shedding light on the world's toughest challenges by unleashing AI-powered imaging for everything and everyone. This means developing fast, accurate, and accessible imaging solutions that provide access to otherwise unattainable sources of knowledge.Orbem is developing deep tech solutions to sustainably feed the world, improve humanhealth, and maximize human potential.Based on years of scientific research at the interface of AI and imaging technology, Orbem was founded in 2019 as a spin-off from the Technical University of Munich. | $64.6M / Series B / Jan 20, 2026 | ||
| Mach is the global leader in off-road autonomy, trusted by top OEMs for over a decade. We deliver proven full stack solutions, which include ruggedized hardware, scalable software, and advanced AI, across agriculture, land care, construction, mining, defense, and maritime. | $7M / Seed / Dec 09, 2025 | ||
| LYRIC BIO develops biomanufacturing platforms for human donor-sourced therapeutics. The company focuses initially on increasing availability of intravenous immunoglobulin, using bioreactors that incorporate high-resolution, laser-printed 3D tissues originating from research at Prellis Biologics. Its approach integrates cell culture systems, processdesign, and scalable hardware to expand throughput while maintaining product consistency. Capabilities include the design of bioreactor components, process monitoring, and quality controls aligned to plasma-derived medicines. The goal is to reduce supply shortages for essential immunoglobulin therapies and create a path to broader access for donor-based biologics. | $6.6M / Seed / Dec 02, 2025 | ||
| SimpliFed is a healthcare technology company that provides virtual maternal care focused on breastfeeding and baby feeding support for families. It offers a telehealth platform that connects parents with certified lactation and baby-feeding specialists, delivering personalized, evidence-based care from pregnancy through the postpartum period. Theplatform includes services such as feeding guidance, remote monitoring, mental health screenings, and ongoing support to improve maternal and infant health outcomes. SimpliFed works closely with healthcare providers and health plans, integrating its services into existing care systems to enhance access and continuity of care. Its approach emphasizes inclusive, judgment-free support, helping parents make informed decisions about feeding methods while addressing both physical and emotional well-being. | $4M / Seed / Feb 04, 2025 | ||
| Concert Bio helps growers harness the vast potential of their plant microbiome. | $1.7M / Oct 24, 2024 | ||
| See all 58 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does The Venture Collective invest in?
The Venture Collective invests primarily in Health Care, Biotechnology and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 58 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does The Venture Collective invest in?
The Venture Collective typically joins rounds of $2.7M–$20M at Seed, $410k–$1.9M at Pre-Seed and $10M–$52M at Series A. These are whole funding-round sizes, not The Venture Collective's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds The Venture Collective took part in.
How do I contact The Venture Collective?
Public channels for The Venture Collective include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at The Venture Collective?
The team at The Venture Collective includes Adam Devine (Venture Partner), Kristin Thayer (Venture Partner) and Cat Hernandez (Partner), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
